Rakovina Therapeutics Inc. (TSXV:RKV)
Canada · Delayed Price · Currency is CAD 0.1200
-0.0100 (-7.69%)
Aug 10, 2026, 11:20 AM EST
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 3.17 million as of August 10, 2026. Its market cap has decreased by -69.37% in one year.
Market Cap
3.17M
Enterprise Value
5.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
ChartMarket Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 3.17M, a decrease of -78.66%. That is a compound annual growth rate of -25.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 3.17M | 50.07% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
| Apr 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kane Biotech | 6.15M |
| MYND Life Sciences | 5.22M |
| PharmaTher Holdings | 5.01M |
| XORTX Therapeutics | 4.85M |
| Innovotech | 4.63M |
| Restart Life Sciences | 4.36M |
| Grey Matters Health | 3.61M |
| Quest PharmaTech | 3.38M |